Therapeutic Effects of Medication Use on Intermittent Claudication: A Network Meta-analysis.
Ma B, Fan X, Liu P.
J Cardiovasc Pharmacol · systematic review; network meta-analysis; journal article · DOI 10.1097/fjc.0000000000000956 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för beraprost. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
18 träffarBeraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
Tian H, Fan F, Geng J, Deng J, Tian H.
J Vasc Res · research support, non-u.s. gov't; journal article · DOI 10.1159/000500424Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
Shen L, Patel JA, Norel X, Moledina S, Whittle BJ, von Kessler K, Sista P, Clapp LH.
Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2019.05.026Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction.
Wang L, Zhu X, Zhao LP, Wang M, Liu X, Chen Y, Chen J, Xu W.
Medicine (Baltimore) · research-article; journal article; observational study · DOI 10.1097/md.0000000000014965Study on bioequivalence of beraprost in healthy volunteers by liquid chromatography with tandem mass spectrometry.
Prasaja B, Harahap Y, Lusthom W, Sofiana A, Safira F, Sandra M, Puspanegara G.
Biomed Chromatogr · randomized controlled trial; journal article · DOI 10.1002/bmc.4403Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats.
Ahmad S, Panda BP, Fahim M, Dhyani N, Dubey K.
Iran J Pharm Res · research-article; journal articleSelexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low <i>β</i>-Arrestin Recruitment and Desensitization Potential.
Gatfield J, Menyhart K, Wanner D, Gnerre C, Monnier L, Morrison K, Hess P, Iglarz M, Clozel M, Nayler O.
J Pharmacol Exp Ther · journal article · DOI 10.1124/jpet.116.239665The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.
Del Pozo R, Hernandez Gonzalez I, Escribano-Subias P.
Expert Rev Respir Med · review; journal article · DOI 10.1080/17476348.2017.1317599Enantioselective Total Synthesis of Beraprost Using Organocatalyst.
Umemiya S, Sakamoto D, Kawauchi G, Hayashi Y.
Org Lett · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.orglett.7b00134A practical synthesis of chiral tricyclic cyclopenta[b]benzofuran, a key intermediate of Beraprost.
Liu X, Tian C, Jiao X, Li X, Yang H, Yao Y, Xie P.
Org Biomol Chem · journal article · DOI 10.1039/c6ob01346eComparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension: A Network Meta-Analysis.
Zhang H, Li X, Huang J, Li H, Su Z, Wang J.
Medicine (Baltimore) · comparative study; review-article; review; network meta-analysis; journal article · DOI 10.1097/md.0000000000002575Catalytic asymmetric formal synthesis of beraprost.
Kobayashi Y, Kuramoto R, Takemoto Y.
Beilstein J Org Chem · research-article; journal article · DOI 10.3762/bjoc.11.285Prostacyclin therapies for the treatment of pulmonary arterial hypertension.
Gomberg-Maitland M, Olschewski H.
Eur Respir J · review; journal article · DOI 10.1183/09031936.00097107Identical twins with primary pulmonary hypertension: beraprost vs epoprostenol.
Berman Rosenzweig E, Schmitt KA, Garofano R, Barst RJ.
Chest · comparative study; journal article; case reports · DOI 10.1378/chest.125.3.1157Beraprost therapy for pulmonary arterial hypertension.
Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R, Beraprost Study Group.
J Am Coll Cardiol · clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/s0735-1097(03)00463-7[Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T, Nakayama T, Ishikita T, Matsuura H.
Nihon Rinsho · review; journal article; english abstractClinical evaluation on combined administration of oral prostacyclin analogue beraprost and phosphodiesterase inhibitor cilostazol.
Fujitani K, Kambayashi J, Murata K, Yano Y, Shinozaki K, Yukawa M, Sakon M, Murata T, Kawasaki T, Shiba E.
Pharmacol Res · clinical trial; journal article · DOI 10.1016/1043-6618(95)80057-3Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T.
Arzneimittelforschung · journal article